Published in Proteome Sci on March 26, 2010
Comparison of the expression of 5 heat shock proteins in benign and malignant salivary gland tumor tissues. Oncol Lett (2013) 0.82
Different immunohistochemical levels of Hsp60 and Hsp70 in a subset of brain tumors and putative role of Hsp60 in neuroepithelial tumorigenesis. Eur J Histochem (2013) 0.81
Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas. Neurosurg Rev (2014) 0.77
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics (2002) 30.58
Small heat shock proteins are molecular chaperones. J Biol Chem (1993) 5.62
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones (2005) 5.22
Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol (2000) 4.89
Heat shock proteins. J Biol Chem (1990) 3.64
Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem (1996) 2.17
HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J (1999) 2.16
On the role of Hsp27 in regulating apoptosis. Apoptosis (2003) 2.02
Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res (2000) 1.99
Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer (1998) 1.94
Heat shock proteins: their role in urological tumors. J Urol (2003) 1.56
The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J Biol Chem (2003) 1.24
HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res (1997) 1.22
Expression of the heat shock protein HSP27 in human ovarian cancer. Clin Cancer Res (1995) 1.10
Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer (2000) 1.07
Heat shock proteins and cell proliferation. FEBS Lett (1991) 0.99
Chaperone proteins and brain tumors: potential targets and possible therapeutics. Neuro Oncol (2005) 0.97
Heat shock proteins and drug resistance. Breast Cancer Res Treat (1994) 0.96
Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation. Electrophoresis (2009) 0.96
Expression and functional activity of heat shock proteins in human glioblastoma multiforme. Neurology (2000) 0.95
Oestrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer. Br J Surg (1991) 0.93
Isoform-specific expression and characterization of 14-3-3 proteins in human glioma tissues discovered by stable isotope labeling with amino acids in cell culture-based proteomic analysis. Proteomics Clin Appl (2009) 0.92
Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics (2002) 0.91
Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group. Cancer Res (1993) 0.91
Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping. J Neurooncol (2001) 0.90
Regulation of the uPA gene in various grades of human glioma cells. Int J Oncol (2001) 0.87
Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions. Cell Mol Neurobiol (1995) 0.84
Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study. Anticancer Res (1997) 0.81
Application of the SILAC (stable isotope labelling with amino acids in cell culture) technique in quantitative comparisons for tissue proteome expression. Biotechnol Appl Biochem (2009) 0.81
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications. Proteomics Clin Appl (2009) 0.81
Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy. Amino Acids (2007) 0.78
Pure spinal epidural cavernous hemangioma. Acta Neurochir (Wien) (2012) 2.38
Spontaneous spinal epidural hematoma: analysis of 23 cases. Surg Neurol (2007) 1.94
Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. J Am Coll Cardiol (2012) 1.61
Central nervous system tuberculoma. J Clin Neurosci (2012) 1.57
Giant cavernous aneurysm associated with a persistent trigeminal artery and persistent otic artery. Korean J Radiol (2009) 1.55
A primary atypical solitary fibrous tumor of the sella mimicking nonfunctional pituitary adenoma: a case report. Acta Neurochir (Wien) (2009) 1.53
Assessment of microscope-integrated indocyanine green angiography during intracranial aneurysm surgery: a retrospective study of 120 patients. Neurol India (2009) 1.52
The long-term outcome predictors of pure microvascular decompression for primary trigeminal neuralgia. World Neurosurg (2012) 1.50
Paradoxical herniation caused by cerebrospinal fluid drainage after decompressive craniectomy. Neurol India (2014) 1.43
Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling. Autophagy (2011) 1.40
Intracystic bleomycin for cystic craniopharyngiomas in children (abridged republication of cochrane systematic review). Neurosurgery (2012) 1.39
Intramedullary spinal tuberculoma: report of three cases. Surg Neurol (2006) 1.33
Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo. Cancer Biol Ther (2010) 1.31
Redox homeostasis: the linchpin in stem cell self-renewal and differentiation. Cell Death Dis (2013) 1.31
Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde? Cancer Lett (2012) 1.31
Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome. J Pediatr (2012) 1.30
IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol (2010) 1.27
Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer (2005) 1.27
Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma. Mol Cancer (2010) 1.24
Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis. RNA Biol (2011) 1.20
Potential anticancer activity of litchi fruit pericarp extract against hepatocellular carcinoma in vitro and in vivo. Cancer Lett (2005) 1.20
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16
CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage. Nucleic Acids Res (2012) 1.16
FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer. Cancer Res (2013) 1.16
Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics (2008) 1.12
Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials (2012) 1.12
Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells. Mol Cell Proteomics (2011) 1.12
Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway. Mol Cell Proteomics (2008) 1.12
Roles of microRNA on cancer cell metabolism. J Transl Med (2012) 1.11
IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. J Immunol (2014) 1.11
Successful treatment of sellar aspergillus abscess. J Clin Neurosci (2010) 1.11
Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet (2014) 1.10
A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs. Mol Ther (2008) 1.09
Towards an optimized culture medium for the generation of mouse induced pluripotent stem cells. J Biol Chem (2010) 1.08
Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage. Chin Med J (Engl) (2009) 1.07
Endovascular treatment of traumatic pseudoaneurysm presenting as intractable epistaxis. Korean J Radiol (2010) 1.06
Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101. J Biol Chem (2011) 1.05
Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Eur J Obstet Gynecol Reprod Biol (2008) 1.04
Keratins modulate the shape and function of hepatocyte mitochondria: a mechanism for protection from apoptosis. J Cell Sci (2009) 1.04
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS One (2011) 1.03
FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol Biochem (2011) 1.03
A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors. PLoS One (2011) 1.03
SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo. Clin Cancer Res (2011) 1.02
Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells. Nanoscale (2011) 1.00
Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis. Mol Cell Proteomics (2012) 0.99
Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. J Control Release (2010) 0.99
Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo. Toxicol Appl Pharmacol (2006) 0.98
Is decompressive craniectomy useless in severe traumatic brain injury? Crit Care (2011) 0.98
BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells. PLoS One (2011) 0.97
Mature cystic teratoma (dermoid cyst) in the sylvian fissure: a case report and review of the literature. J Child Neurol (2011) 0.97
JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells. Biochem J (2012) 0.96
Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials. Crit Care (2012) 0.96
Triterpene acids isolated from Lagerstroemia speciosa leaves as alpha-glucosidase inhibitors. Phytother Res (2009) 0.96
Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation. Electrophoresis (2009) 0.96
Activation of the hypothalamus characterizes the response to acupuncture stimulation in heroin addicts. Neurosci Lett (2007) 0.95
No association between hypertension and risk for Alzheimer's disease: a meta-analysis of longitudinal studies. J Alzheimers Dis (2011) 0.95
Prognostic evaluation of epidermal fatty acid-binding protein and calcyphosine, two proteins implicated in endometrial cancer using a proteomic approach. Int J Cancer (2008) 0.95
Growing skull fracture stages and treatment strategy. J Neurosurg Pediatr (2012) 0.94
Deconvoluting the role of reactive oxygen species and autophagy in human diseases. Free Radic Biol Med (2013) 0.94
Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Phytother Res (2008) 0.94
Abnormalities of white matter microstructure in unmedicated obsessive-compulsive disorder and changes after medication. PLoS One (2012) 0.94
Pyrvinium targets autophagy addiction to promote cancer cell death. Cell Death Dis (2013) 0.93
Chloroquine inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis. Cancer Invest (2009) 0.93
Antitumor and antimetastatic activities of vesicular stomatitis virus matrix protein in a murine model of breast cancer. J Mol Med (Berl) (2009) 0.93
Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model. J Exp Clin Cancer Res (2008) 0.92
Hepatitis B virus X protein (HBx) induces G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinase. Oncol Rep (2009) 0.92
Distinct contributions of angiogenesis and vascular co-option during the initiation of primary microtumors and micrometastases. Carcinogenesis (2011) 0.92
Preparative isolation and purification of three rotenoids and one isoflavone from the seeds of Millettia pachycarpa Benth by high-speed counter-current chromatography. J Chromatogr A (2007) 0.92
Isoform-specific expression and characterization of 14-3-3 proteins in human glioma tissues discovered by stable isotope labeling with amino acids in cell culture-based proteomic analysis. Proteomics Clin Appl (2009) 0.92
Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev (2012) 0.92
Symptomatic Rathke cleft cyst. J Clin Neurosci (2012) 0.92
Optimizing high-performance liquid chromatography method for quantification of glucosamine using 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate derivatization in rat plasma: application to a pharmacokinetic study. Biomed Chromatogr (2008) 0.91
Surgical management of traumatic intracranial pseudoaneurysms: a report of 12 cases. Neurol India (2008) 0.91
Effect of MLC leaf position, collimator rotation angle, and gantry rotation angle errors on intensity-modulated radiotherapy plans for nasopharyngeal carcinoma. Med Dosim (2013) 0.91
Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model. Microvasc Res (2010) 0.91
Central nervous system cryptococcoma in immunocompetent patients: a short review illustrated by a new case. Acta Neurochir (Wien) (2009) 0.91
Quantitative proteomics for cancer biomarker discovery. Comb Chem High Throughput Screen (2012) 0.90
Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo. In Vivo (2009) 0.90
Prokaryotic expression, purification of a new tumor-relative protein FAM92A1-289 and its characterization in renal cell carcinoma. Cancer Lett (2008) 0.90
Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. Int J Pharm (2012) 0.90
Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects. BMC Cancer (2014) 0.90
Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment. J Proteomics (2013) 0.89
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma. Cancer Chemother Pharmacol (2008) 0.89
5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice. BMC Cancer (2010) 0.89
Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid. Cancer Chemother Pharmacol (2007) 0.89